Uveitis Withdrawn Phase 1 / 2 Trials for Ustekinumab (DB05679)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01647152Ustekinumab for Active Sight-Threatening UveitisTreatment